Trending News

District Court Rejects First Amendment Challenge to California Climate Disclosure Requirements

This Week in 340B: August 5 – 11, 2025

DOL Resurrects PAID Program to Supervise Employers’ Self-Audits and Settlements of Potential FLSA and FMLA Violations

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Eagle Pharmaceuticals Announces 2025 Annual Meeting Date
Posted On Monday, August 18, 2025
Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
Posted On Monday, August 18, 2025
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
Posted On Monday, August 18, 2025
ORIC® Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical Officer
Posted On Monday, August 18, 2025
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Posted On Monday, August 18, 2025
HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results
Posted On Monday, August 18, 2025
BioNTX Announces 2025 Tech Transfer Showcase Finalists Pitch Competition at the 2025 iC³® Life Science & Healthcare Innovation Summit
Posted On Monday, August 18, 2025
Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025
Posted On Monday, August 18, 2025
European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
Posted On Monday, August 18, 2025
Capricor Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of Novel Exosome-Based Vaccine
Posted On Monday, August 18, 2025
Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025
Posted On Monday, August 18, 2025
Quoin Pharmaceuticals Appoints New Chief Financial Officer to Support Commercialization Strategy
Posted On Monday, August 18, 2025
Myriad Genetics Appoints Ben Wheeler Chief Financial Officer
Posted On Monday, August 18, 2025
Journey Medical Corporation to Present at the Emerging Growth Conference
Posted On Monday, August 18, 2025
Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue
Posted On Monday, August 18, 2025
Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
Posted On Monday, August 18, 2025
Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA
Posted On Sunday, August 17, 2025
Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001
Posted On Friday, August 15, 2025
4DMT Announces New Employment Inducement Grants
Posted On Friday, August 15, 2025
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, August 15, 2025
Tonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of Fibromyalgia
Posted On Friday, August 15, 2025
Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation
Posted On Friday, August 15, 2025
AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Posted On Friday, August 15, 2025
Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Posted On Friday, August 15, 2025
Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market
Posted On Friday, August 15, 2025

Print